NormOxys Raises $17.5 Million
NormOxys Inc., a Wellesley, Mass.-based developer of drugs that enhance the body’s ability to deliver oxygen to diseased tissues, has raised $17.5 million in Series B funding. Care Capital led the round, and was joined by return backer Index Ventures. The company previously raised $12.5 million.
24 May 2010•3 mins read
